Tokyo, Japan and Cambridge, UK, 3 April 2024 - Nxera Pharma (“Nxera” or “the Company”; TSE: 4565) – formerly known as Sosei Group or Sosei Heptares – today announces the appointment of Japan pharmaceutical sector expert, Mr. Patrick Branch, as Head of Business Development for Japan and the APAC region.
Viewing entries tagged
pharmaceutical
Global IT services and consulting major Cognizant is tapping generative AI (gen AI) technology along with the Nvidia BioNeMo platform to help improve productivity of drug discoveries and speed up its market reach pushing growth in its health sciences vertical.
FTI Consulting, announced the appointment of Anne Winter as a Senior Managing Director within the Company’s Health Solutions practice, where she will focus on Medicaid managed care and the pharmaceutical industry.
Tata Consultancy Services Ltd. has turned its sights on the $300 billion business-to-business ecommerce and the direct-to-consumer side of retail as an area for new business growth and to help global clients tap customer insights.
Big data is an area that has seen rapid growth across a variety of industries in recent years – not least among pharmaceutical companies.
Alira Health, a leading international advisory firm dedicated to advancing healthcare and life sciences, announced it has closed a $35M equity financing led by Creadev, an evergreen investment company backed by the Mulliez family.
Prescient Healthcare Group , a global product strategy advisory firm serving the pharmaceutical and biotech industries, has announced the recent appointment of two new senior members: Emma Leung and Matt Majer.
Accenture and ServiceNow have joined forces to launch a global business unit dedicated to digital transformation projects.
EVERSANA™, the leading provider of commercial services to the life science industry, announced the acquisition of HVH Precision Analytics and its predictive analytics platform.
IT services major Infosys on Monday launched a personalised medicine solution for the pharmaceutical industry.
A company that provides health economic research, communications, and consulting services to the global pharmaceutical industry has been acquired by a US private equity firm.